Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¼Ò¾Æ ºñ¸¸¿¡¼­ ´ë»çÁõÈıºÀÇ °íÂû The Metabolic Syndrome in Obese Children

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 2004³â 7±Ç 2È£ p.228 ~ 238
¿°Çý¿ø, ÀÌÇöÁÖ, ¼­Á¤¿Ï, Á¶¼öÁø, ½ÅÁö¼±, ¹Ú¼ÒÀº,
¼Ò¼Ó »ó¼¼Á¤º¸
¿°Çý¿ø ( Yom Hye-Won ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¸ñµ¿º´¿ø ¼Ò¾Æ°ú

ÀÌÇöÁÖ ( Lee Hyun-Ju ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
¼­Á¤¿Ï ( Seo Jeong-Wan ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¸ñµ¿º´¿ø ¼Ò¾Æ°ú
Á¶¼öÁø ( Cho Su-Jin ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
½ÅÁö¼± ( Shin Ji-Sun ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
¹Ú¼ÒÀº ( Park So-Eun ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç

Abstract

¸ñ Àû: ¼Ò¾Æ ºñ¸¸Å¬¸®´Ð¿¡¼­ ½ÃÇàÇÏ´Â ¼±º°°Ë»ç·Î ´ë»çÁõÈıºÀÇ À§ÇèÀÎÀÚ¸¦ ¹Ì¸® ÀÎÁöÇÏ¿© ºñ¸¸¾Æ°¡ Ä¡·á¸¦ Áö¼ÓÀûÀ¸·Î ÇÒ ¼ö ÀÖµµ·Ï ÁöµµÇϴµ¥ µµ¿òÀ» ÁÖ°íÀÚ ÇÏ¿´´Ù.

´ë »ó: 2000³â 2¿ùºÎÅÍ 2004³â 6¿ù±îÁö ÀÌ´ë ¸ñµ¿º´¿ø ¼Ò¾Æ ºñ¸¸Å¬¸®´ÐÀ» ¹æ¹®ÇÑ ºñ¸¸¾Æ¿¡¼­ Àǹ«±â·ÏÀÌ Ãæ½ÇÇÏ°í üÁú·®Áö¼ö(BMI)°¡ 95 ¹éºÐÀ§¼ö ÀÌ»óÀÎ 88¸í(³² 52¸í, ¿© 36¸í)À» ´ë»óÀ¸·Î ÇÏ¿´´Ù.

¹æ ¹ý: ºñ¸¸¾Æ¿¡¼­ BMI¸¦ °è»êÇÏ°í Ç÷¾ÐÀº ¾ÈÁ¤»óÅ¿¡¼­ µÎ ¹ø ÃøÁ¤ÇÏ¿© Æò±ÕÀ» ±¸ÇÏ¿´´Ù. 12½Ã°£ °øº¹ ÈÄ¿¡ Ç÷û ÁöÁú(Áß¼ºÁö¹æ, ÃÑÄÝ·¹½ºÅ×·Ñ, °í¹Ðµµ ÄÝ·¹½ºÅ×·Ñ, Àú¹Ðµµ ÄÝ·¹½ºÅ×·Ñ), Ç÷´ç°ú Ç÷Áß Àν¶¸° ³óµµ¸¦ ÃøÁ¤ÇÏ¿´´Ù. Àν¶¸° ÀúÇ×¼º ÁöÇ¥
·Î fasting insulin to glucose ratio (FIGR), homeostasis model assessment of insulin resistance (HOMA-IR), quantitative insulin sensitivity check index (QUICKI) ¸¦ ÀÌ¿ëÇÏ¿´´Ù.

°á °ú: ºñ¸¸¾Æ 88¸í Áß 53¸í(60.2%)¿¡¼­ Çϳª ÀÌ»óÀÇ ´ë»çÁõÈıºÀÇ À§Çè ÀÎÀÚ¸¦ º¸¿´´Ù. °íÇ÷¾ÐÀº 13¸í(14.8%), Áß¼ºÁö¹æ ¡Ã150 mg/dL 13¸í(14.8%), ÃÑÄÝ·¹½ºÅ×·Ñ ¡Ã200 mg/dL 23¸í(26.1%), °í¹Ðµµ ÄÝ·¹½ºÅ×·Ñ ¡Â40 mg/dL 13¸í(14.8%), Àú¹Ðµµ ÄÝ·¹½º
Å×·Ñ ¡Ã130 mg/dL 11¸í(12.5%)À̾úÀ¸¸ç °íÀν¶¸° Ç÷ÁõÀº 11¸í(12.5%)À̾ú´Ù. BMI´Â ¼öÃà±â Ç÷¾Ð(r=0.535), °í¹Ðµµ ·¹½ºÅ×·Ñ(r=-0.214), Àν¶¸° ³óµµ (r=0.342), HOMA-IR (r=0.346), FIGR (r=0.329), QUICKI (r=-0.22)¿Í À¯ÀÇÇÑ »ó°ü °ü°è¸¦ º¸¿´´Ù. Àν¶¸° ³óµµ(r=0.233), HOMA-IR (r=0.234)Àº ¼öÃà ±â Ç÷¾Ð°ú, FIGRÀº ¼öÃà±â Ç÷¾Ð(r=0.227) ¹× Àú¹Ðµµ ÄÝ·¹½ºÅ×·Ñ(r=0.223)°ú, QUICKI´Â Ç÷´ç(r=-0.308)°ú °¢°¢ À¯ÀÇÇÑ »ó°ü°ü°è¸¦ º¸¿´´Ù. ¼±º°°Ë»ç¿¡¼­ ´ë»çÁõÈıºÀÇ À§Çè ÀÎÀÚ°¡ ¸¹À»¼ö·Ï Àν¶¸° ÀúÇ×¼º
(HOMA-IR, FIGR)ÀÌ À¯ÀÇÇÏ°Ô Áõ°¡ÇÏ¿´´Ù. ÇÑÆí Àν¶¸° ÀúÇ×¼ºÀ» °¡Àå Àß ¼³¸íÇÏ´Â ÀÎÀڷδ BMI,Áß¼ºÁö¹æ, ÃÑÄÝ·¹½ºÅ×·ÑÀ̾ú´Ù.

°á ·Ð: ¼Ò¾Æ ºñ¸¸Å¬¸®´ÐÀ» ¹æ¹®ÇÏ´Â ºñ¸¸¾Æ¿¡¼­ ÀÌ¹Ì ´ë»çÁõÈıºÀÌ ½ÃÀ۵ǰí ÀÖÀ¸¹Ç·Î Çൿ ¼öÁ¤, ½Ä»çÁ¶Àý ¹× ¿îµ¿ ó¹æ»Ó ¾Æ´Ï¶ó Ç÷¾Ð, ÁöÁú, Ç÷´ç, Àν¶¸° ³óµµ µîÀ» Á¤±âÀûÀ¸·Î °Ë»çÇÏ¿© Àû±ØÀûÀ¸·Î °ü¸®ÇØ¾ß ÇÑ´Ù.

Purpose:Obesity is rapidly increasing in Korean children. Obesity is a risk factor for cardiovascular morbidity and is frequently associated with hypertension, diabetes mellitus and coronary artery disease. This study was designed to evaluate risk factors of the metabolic syndrome in obese children.

Methods:From February 2000 to June 2004, eighty eight obese (body mass index > or =95th percentile) children aged 4 to 15 years were included. We measured serum lipid levels (total cholesterol, triglyceride, HDL cholesterol, LDL cholesterol), fasting sugar levels and insulin levels. Insulin resistance was determined by homeostasis model assessment, fasting insulin/glucose ratio and quantitative insulin sensitivity check index.

Results:Clustering of risk factors for the metabolic syndrome in obese children demonstrated that 60.2% had more than one risk factors. Hypertension (14.8%), hypertriglyceridemia (14.8%), HDL-hypocholesterolemia (14.8%), LDL-hypercholesterolemia (12.5%) and hyperinsulinemia (12.5%) were observed. As BMI increased, there was statistically significant increase in systolic blood pressure, insulin and insulin resistance values. Insulin resistance was correlated to systolic blood pressure, serum lipid and insulin levels. The more risk factors for the metabolic syndrome obese children had, the higher was their insulin resistance.

Conclusion:The increase in insulin resistance and clustering of risk factors for the metabolic syndrome are already apparent in obese children. Monitoring these risk factors for the metabolic syndrome should become a part of routine medical care for obese children.

Å°¿öµå

Obesity;Children;Metabolic syndrome

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS